摘要
[目的 ]评价斯奇康对防治支气管哮喘的作用。 [方法 ] 6 0名支气管哮喘病儿随机分为治疗组与对照组 ,治疗组 40例 ,给予斯奇康 0 .5mg肌肉注射 ,每周 2次 ,2个月为一疗程。对照组 2 0例 ,给予核酪 5mL每日 2次 ,2个月为一疗程。第一个疗程无效者应用第二个疗程。 [结果 ] 治疗组的总有效率高于对照组 (P <0 .0 5 ) ,完成两个疗程后的总有效率治疗组明显优于对照组 (P <0 .0 0 1)。 [结论 ] 斯奇康是一种有效的治疗小儿哮喘的免疫调节剂 。
Objective] To evaluate the efficacy of BCG polyose nucleic acid in treating bronchial asthma of children .[Methods] Sixty Patients with bronchial asthma were randomized into 2 groups.The treatment group consisted of forty patients (M23,F17,age6.9±3.0) received BCG polyose nucleic acid 0.5ml intramuscular twice per week for 2 months. The control group consisted of twenty patients(M13,F7,age6.5±3.4) received nucleic acid and casein hydrolyzates 5ml oral twice daily for 2 months.For patients who had been treated for 2 months without improvement were given BCG polyose nucleic acid for another next 2 months.[Results] The total response rate of the treatment group was higher than that of the control(P<0.05). By the end of 4 months treatment ,the total response rate of the treatment group was apparently better than that of the control(P<0.001).[Conclusion] BCG polyose nucleic acid is one of the effective immuno modulator in treating bronchial asthma of children. No adverse reaction was observed.
出处
《上海预防医学》
CAS
2000年第6期271-272,共2页
Shanghai Journal of Preventive Medicine
